Oncology & Cancer

Developing a new treatment for lung cancer

In Norway, more than 3,300 people contract lung cancer every year. It is the second most common form of cancer among both women and men, after breast and prostate cancer, respectively. It also exhibits the highest cancer ...

Oncology & Cancer

Genome-wide intricacies of cancer inhibitor untangled

A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation and alter the epigenome, according to a Northwestern Medicine study published ...

page 9 from 40